Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueEBIATGross ProfitLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetShares IssuedShares OutstandingShares Outstanding
Ratios

AVITA Medical (RCEL) EBIAT (2018 - 2025)

AVITA Medical filings provide 8 years of EBIAT readings, the most recent being -$11.6 million for Q4 2025.

  • On a quarterly basis, EBIAT changed 0.28% to -$11.6 million in Q4 2025 year-over-year; TTM through Dec 2025 was -$48.6 million, a 21.44% increase, with the full-year FY2025 number at -$48.6 million, up 21.44% from a year prior.
  • EBIAT hit -$11.6 million in Q4 2025 for AVITA Medical, up from -$13.2 million in the prior quarter.
  • In the past five years, EBIAT ranged from a high of -$4.7 million in Q2 2021 to a low of -$18.7 million in Q1 2024.
  • Median EBIAT over the past 5 years was -$9.7 million (2022), compared with a mean of -$10.2 million.
  • Biggest five-year swings in EBIAT: skyrocketed 63.47% in 2021 and later crashed 102.36% in 2024.
  • AVITA Medical's EBIAT stood at -$5.9 million in 2021, then increased by 10.0% to -$5.4 million in 2022, then crashed by 31.98% to -$7.1 million in 2023, then crashed by 64.03% to -$11.6 million in 2024, then decreased by 0.28% to -$11.6 million in 2025.
  • The last three reported values for EBIAT were -$11.6 million (Q4 2025), -$13.2 million (Q3 2025), and -$9.9 million (Q2 2025) per Business Quant data.